Hypersensitivity Reaction to Midazolam - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Anesthesia & Critical Care Année : 2015

Hypersensitivity Reaction to Midazolam

Résumé

The incidence of hypersensitivity due to anesthesia in children is 1/7741. Hypersensitivity reactions are a result of either an immunologic mechanism (allergic or anaphylactic reaction) generally mediated by immunoglobulines E (IgE) or immunoglobulines G (IgG) antibodies or a non immunologic mechanism (pseudo-allergic or anaphylactoid reaction) related to different phenomenon such as non specific histamine liberation. In children, latex is the principal cause of anaphylaxis during anesthesia (41%) followed by non depolarizing muscle relaxants (19%) and antibiotics (9%); anaphylaxis due to hypnotics is rare (2,43%) and midazolam is responsible in only 0,5% of the cases. Anaphylaxis during anesthesia is mediated by immunoglobulines E antibodies in 42% of the cases in children. We describe here a case of a six year old child who presented a hypersensitivity skin reaction to midazolam thirty minutes after intrarectal midazolam administration. It was a generalized rash of the whole body without pruritis. The prick tests realized six weeks after the reaction were negative and the intradermoreaction was positive to midazolam confirming the hypersensitivity reaction to midazolam. A hypersensitivity identification card to midazolam was delivered to the patient.
Fichier principal
Vignette du fichier
JACCOA-02-00057.pdf (435.51 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-01870431 , version 1 (25-01-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

C Kumba, N Valade, F Montagut, Anne Filleron, Tu-Anh Tran, et al.. Hypersensitivity Reaction to Midazolam. Journal of Anesthesia & Critical Care, 2015, 2 (3), ⟨10.15406/jaccoa.2015.02.00057⟩. ⟨hal-01870431⟩

Collections

INSERM
64 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More